Halgen

Halgen, based in Zhongshan, China, specializes in innovative gene technology solutions that enhance efficiency across multiple sectors, including healthcare and logistics. Halgen operates in the gene technology field, providing advanced solutions to its clients. Founded in 2014 in Zhongshan, China, the company has completed one significant deal. Details about strategic pivots or subsidiaries are not available.

The most recent deal date is June 18, 2025, when Halgen raised venture funding from Zhongshan Xiangshang Private Equity Investment Fund Management. Halgen specializes in providing innovative solutions that cater to a diverse range of industries through its core product offerings. The company’s primary focus is on advanced technologies designed to streamline operations and enhance efficiency, particularly in sectors such as healthcare, manufacturing, and logistics. Halgen's products integrate seamlessly into existing systems, offering solutions that improve productivity and reduce costs.

Serving both B2B and direct-to-consumer markets, Halgen's client base includes healthcare providers, manufacturing firms, and logistics companies primarily across North America and Europe. These products have been released at various stages over the past few years, reflecting the company's ongoing dedication to innovation and responsiveness to market demands. Halgen generates revenue through a structured approach that encompasses direct sales and strategic partnerships, focusing on both B2B and direct-to-consumer models. The transactions typically involve clients purchasing subscriptions for ongoing access to Halgen’s flagship products, which may include specialized software and hardware solutions tailored to industry needs.

Clients may engage in annual contracts that provide not only the products themselves but also associated support services. The revenue stream is bolstered by partnerships with distributors and wholesalers, expanding the company’s reach into various geographical markets. Pricing plans for these offerings are designed to reflect the value provided, ensuring competitive positioning within the market while catering to the needs of a diverse customer base. Looking ahead, Halgen is strategizing to launch new products designed to address market demands, with plans for introduction in late 2025.

The company aims to expand into additional markets in Europe and North America by mid-2026. The recent venture funding raised in June 2025 will support the development of these new products and the expansion initiatives.